切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2006, Vol. 02 ›› Issue (04) : 184 -187. doi: 10.3877/cma.j.issn.1673-5250.2006.04.102

专家述评

绝经后激素治疗的研究现状
黄薇   
  1. 四川大学华西第二医院(成都,610041)
  • 出版日期:2006-07-21
  • Published:2006-07-21
引用本文:

黄薇. 绝经后激素治疗的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2006, 02(04): 184-187.

1 Stamper MJ, Colditz GA, Willett WC, et al.Postmenopausal estrogen therapy and cardiovascular disease.Ten-year follow-up from the Nurse's Health Study.N Eng J Med, 1991,325:756-762.
2 Hulley S, Grady D,Bush T, et al.Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women.Heart and Estrogen/progestin Replacement Study(HERS)Research Group.JAMA, 1998,280:605-613.
3 Grady D,Herrington D,Bitter V,et al.Cardiovascular disease outcome 6.8 years of hormone therapy.JAMA, 2002,288:49-57.
4 Writing group for the women's health initiative investigators.Risks and benefits of estrogen plus progestin in healthy postmenopausal women.JAMA, 2002,288:321-333.
5 The Women's Health Initiative Steering Committee.Effects of conjugated equine estrogen in postmenopausal women with hysterectomy.JAMA, 2004, 291:1701-1712.
6 Million Women Study Collaborators.Breast cancer and hormone replacement therapy in the million women study.Lancet, 2003,362:419-427.
7 Cardozo L, Bachmann G,McClish D,et al.Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women:second report of the Hormones and Urogenital Therapy Committee.Obstset Gynecol, 1998,92:722-727.
8 Wells G,Tugwell P,Shea B,et al.Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women.Endocr Rev, 2002,23: 529-539.
9 Zandi PP,Carlson MC, Plassman BL, et al.Hormone replacement therapy and incidence of Aalzheimer's disease in older women:the UCHE County Study.JAMA, 2002,288:2123-2129.
10 Shunmaker SA, Legault C, Rapp SR, et al.Estrogen plus progestin and the risk of dementia and mild cognitive impatient in postmenopausal women.The Women's Health Memory Study:a randomized controlled trial.JAMA, 2003,289:2651-2662.
11 Collaborative Group on hormone factors in breast cancer.Breast cancer and hormone replacement therapy:collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer.Lancet, 1997, 350:1047-1059.
12 Herrington DM, Reboussin DM,Brosnihan KB, et al.Effects of estrogen replacement ont the progression of coronary artery atherosclerosis.N Eng J Med, 2000,343:522-529.
13 Cherry N,Gilmour K,Hannaford P,et al.Oestrogen therapy for prevention of reinfarction in postmenopausal women:a randomized placebo controlled trial.Lancet, 2002,360: 2001-2008.
14 The writing group for the PEPI Trial Effects of estrogen or estrogen/progestin regimen on heart disease risk factors in postmenopausal women.The Postmenopausal Estrogen/Progestin Interventions(PEPI)Study.JAMA, 1995,273:199-208.
15 Perez-Gutthann S, Garcia Rodriguez LA, Castellsague J, et al.Hormone replacement therapy and risk of venous thromboembolism:population based case-control study.BMJ,1997,314:796-800.
16 Grady D, Gebretsadik T, Ernster VL, et al.Hormone replacement therapy and endometrial cancer risk:a meta-analysis.Obstet Gynecol, 1995,85:304-313.
17 Schairer C,Lubin J,Troisi R, et al.Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.JAMA, 2000, 283:485-491.
18 Grodsyein F, Newcomb PA, Stampfer MJ.Postmenopausal hormone therapy and the risk of colorectal cancer:a review and meta-analysis.Am J Med, 1999,106:574-582.
19 Riman T,Dickman P,Nillson S,et al.Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.J Natl Cancer Inst, 2002,94:971-978.
20 Stamper MJ, Hu FB,Manson,et al.Primary prevention of coronary heart disease in women through diet and lifestyle.N Eng J Med, 2000,343:16-22.
21 Ettinger B, Black DM, Mitlak BH, et al.Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene results from a 3-year randomized clinical trial.multiple outcomes of raloxifene evaluation(MORE)investigation.JAMA, 1999,282:637-645.
22 Kloosterboer HJ.Tissue-selective effects of tibolone on the breast.Maturitas, 2004, 49:S1-S15.
23 Krebs EE, Ensrud KE.MacDonald R, et al.Phytoestrogens for treatment of menopausal symptoms:a systematic review.Obstet Gynecol, 2004, 104:824-836.
No related articles found!
阅读次数
全文


摘要